Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa/IIb trial of QD202 in acute ischemic stroke
CTR20251295Phase 2Terminated
- Sponsor
- Quatidi Biotech
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QD202 in ischemic stroke, sponsored by Quatidi Biotech. Started Apr 2025; status: terminated.
02
Drugs
QD202
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20251295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251295.